Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Next Tech 3 New Technology Investment Fund SMR NUSCALE POWER Corp 13G/A 3.4% 2y
GOLDMAN SACHS GROUP INC QBTS D-Wave Quantum Inc. 13G/A 7% 2y
Bhat Laxminarayan RVPH Reviva Pharmaceuticals Holdings, Inc. 13D/A 10.2% 2y
3DOM Alliance Inc. NCNC noco-noco Inc. Ordinary Share 13G 66.9% 2y
Funicular Funds, LP SYBX Synlogic, Inc. 13D 36% 2y
Board of Directors of MetLife, Inc., as an entity MET Metlife Inc 13D/A 16.2% 2y
Michael Moore VMD Viemed Healthcare, Inc. 13D/A 6.5% 2y
Radoff Bradley Louis LFVN Lifevantage Corp 13D/A 6.7% 2y
STILWELL JOSEPH SFBC Sound Financial Bancorp, Inc. 13D/A 16.1% 2y
Dayton Judd LFVN Lifevantage Corp 13D/A 5.9% 2y
GAMCO INVESTORS, INC. ET AL RUSHA Rush Enterprises Inc Tx 13D/A 6.77% 2y
Starboard Value LP ACTG Acacia Research Corp 13D/A 61.2% 2y
ALSTODT LANCE BRTX BioRestorative Therapies, Inc. 13D/A 11.2% 2y
Deerfield Management Company, L.P. LRMR Larimar Therapeutics, Inc. 13D/A 39.2% 2y
Christopher Scott Ginieczki, as Personal Representative of the Estate of Geoffrey S. M. Hedrick IA Innovative Solutions & Support Inc 13D/A 7.24% 2y
Silva, Francisco BRTX BioRestorative Therapies, Inc. 13D/A 10.7% 2y
TCG Crossover GP II, LLC MLYS Mineralys Therapeutics, Inc. 13G 6.4% 2y
Lind Global Fund II LP THC Tenet Healthcare Corp 13G 9.9% 2y
Mostafa Kandil SWVL Swvl Holdings Corp 13D/A 26.7% 2y
Emilio Fernando Azcarraga Jean TV Grupo Televisa, S.A.B. 13D/A 49.67% 2y
Millennium Management LLC BBOT BridgeBio Oncology Therapeutics, Inc. 13G 5.8% 2y
GIC Private Ltd TBBB Bbb Foods Inc 13G 8.08% 2y
ANTA Sports Products Limited AS Amer Sports, Inc. 13D 46% 2y
ROSENFELD ERIC LEGT Legato Merger Corp. III 13D 7.2% 2y
Phoenix Financial Ltd. TSEM Tower Semiconductor Ltd 13G/A 4.94% 2y
FountainVest China Capital Partners GP3 Ltd. AS Amer Sports, Inc. 13D 13.7% 2y
Dennis J. Wilson AS Amer Sports, Inc. 13D 20.6% 2y
Iroquois Capital Management, LLC PRSO Peraso Inc. 13G 9.99% 2y
D. E. Shaw & Co., L.P. CHGG Chegg, Inc 13G 5.5% 2y
STRS OHIO GBDC GOLUB CAPITAL BDC, Inc. 13G/A 4.1% 2y
KLEMP WALTER V AMIX Autonomix Medical, Inc. 13D 16% 2y
Bowen Holding LP BOWN Bowen Acquisition Corp Ordinary Shares 13D 6.2% 2y
Createcharm Holdings Ltd. BOWN Bowen Acquisition Corp Ordinary Shares 13D 16.3% 2y
EcoR1 Capital, LLC MORF Morphic Holding, Inc. Common Stock 13G/A 0.4% 2y
No Street GP LP FNKO Funko, Inc. 13G/A 0% 2y
Think Investments LP TASK TaskUs, Inc. 13G 7.6% 2y
First Trust Capital Management L.P. SVII Spring Valley Acquisition Corp. II Class A Ordinary Shares 13G 9.72% 2y
Red Oak Partners, LLC JETMF Global Crossing Airlines Group Inc. 13G/A 9.4% 2y
Nortye International Limited ANL Adlai Nortye Group Ltd. 13G 5.4% 2y
First Trust Capital Management L.P. SEDA SDCL EDGE Acquisition Corporation 13G 9.95% 2y
First Trust Capital Management L.P. SKGR SK Growth Opportunities Corporation Class A Common Stock 13G 6.46% 2y
Rosalind Advisors, Inc. MYO Myomo, Inc. 13G/A 9.2% 2y
Yi ZHANG LSBWF LakeShore Biopharma Co., Ltd. 13G 42.6% 2y
First Trust Capital Management L.P. TRTL TortoiseEcofin Acquisition Corp. III 13G 9.82% 2y
Innovation Endeavors II, L.P. BMR Beamr Imaging Ltd. 13G 8% 2y
Ronald F. Clarke CPAY Corpay, Inc. 13G 5.6% 2y
John P. D. Cato CATO Cato Corp 13G/A 14.5% 2y
EcoR1 Capital, LLC AVIR Atea Pharmaceuticals, Inc. 13G/A 8.4% 2y
PRINCIPAL FINANCIAL GROUP INC BCOW 1895 Bancorp of Wisconsin, Inc. 13G/A 9.38% 2y
Nortye Talent Limited ANL Adlai Nortye Group Ltd. 13G 8.1% 2y